EUVIMEDObjevte EUVIMED
Crossref

β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models

Yongqiang Xiong, Wu Luo, Jiaxi Ye, Yaqian Cui, Xiangsheng Zheng, Leiming Jin, Shuaijie Lou, Qianhui Zhang, Ao Wang, Yi Fang, Tianyang Jin, Mengsha Lin and 4 more

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70161 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025. Written by Yongqiang Xiong and 15 co-authors. Institution: Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Major MEDLINE topics: PPAR alpha, Sesquiterpenes, Fatty Liver, Non-alcoholic Fatty Liver Disease. Cited 1 times so far (Crossref); 43 references. Funded by: Wenzhou Medical Universitity Distinguished Young Scholar Project, Science and Technology Plan Project of Wenzhou Municipality, Zhejiang Provincial Health Science and Technology Plan.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Metabolic dysfunction‐associated steatohepatitis (MASH) is an escalating global health concern with few effective pharmacological treatment options available. β‐elemene (ELE) is a natural product derived from Curcuma Rhizoma , which has anti‐tumour and anti‐inflammatory effects. However, its efficacy and molecular mechanism in MASH have not been elucidated. Experimental Approach Two diet‐induced MASH models were used to evaluate the therapeutic potential of ELE in vivo . Additionally, RNA sequencing, network pharmacological analysis, and target validation were performed to elucidate the underlying mechanisms. Key Results ELE markedly ameliorated lipid dysfunction and the inflammatory response in MASH mice and fatty acids‐stimulated hepatocytes. RNA‐sequencing analysis indicated that ELE exerted its therapeutic effects through activating the PPARα signalling pathway. Particularly, we found that ELE directly binds to PPARα protein, preventing its degradation via K48‐linked polyubiquitination. Notably, the protective effects of ELE on MASH were abolished in the absence of PPARα. Conclusion and Implications Our studies reveal that ELE is a novel stabiliser of PPARα, effectively inhibiting its ubiquitin‐mediated degradation in MASH. By preserving the PPARα signalling pathway, ELE enhances lipid homeostasis and relieves the inflammation. Therefore, ELE holds significant potential as a therapeutic candidate for the treatment of MASH.

Subjects

MeSH terms (MEDLINE)

PPAR alphaSesquiterpenesFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsMiceMaleMice, Inbred C57BLDiet, High-FatDisease Models, AnimalHumansHepatocytes

Author keywords

HFDMASHPPARαlipid metabolismβ‐elemene

Substances

PPAR alphaSesquiterpenesbeta-elemenePpara protein, mouse

Authors and institutions

  • Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Endocrinology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chemical Biology Research Center, Wenzhou Medical University, Wenzhou, China.
  • School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, China.

ORCID profiles: Guang Liang

Funding

  • Wenzhou Medical Universitity Distinguished Young Scholar Project
  • Science and Technology Plan Project of Wenzhou Municipality
  • Zhejiang Provincial Health Science and Technology Plan
  • Postdoctoral Fellowship Program of CPSF
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Cite

APA

Xiong, Y., Luo, W., Ye, J., Cui, Y., Zheng, X., Jin, L., Lou, S., Zhang, Q., Wang, A., Fang, Y., Jin, T., Lin, M., Dong, H., Liang, G., Hu, X., & Zhu, W. (2025). β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models. British Journal of Pharmacology. https://doi.org/10.1111/bph.70161

Vancouver

Xiong Y, Luo W, Ye J, Cui Y, Zheng X, Jin L, et al. β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models. British Journal of Pharmacology. 2025. doi:10.1111/bph.70161

BibTeX
@article{Xiong2025,
  author = {Xiong, Yongqiang and Luo, Wu and Ye, Jiaxi and Cui, Yaqian and Zheng, Xiangsheng and Jin, Leiming and Lou, Shuaijie and Zhang, Qianhui and Wang, Ao and Fang, Yi and Jin, Tianyang and Lin, Mengsha and Dong, Hui and Liang, Guang and Hu, Xiang and Zhu, Weiwei},
  title = {β‐elemene ameliorates metabolic dysfunction‐associated steatohepatitis by targeting PPARα in experimental diet‐induced models},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70161}
}
Start for free →